Pith. sign in

REVIEW 4 major objections 5 minor 44 references

Accurate early detection of Parkinson's disease from SPECT imaging through Convolutional Neural Networks

T0 review · 4 major / 5 minor · reviewed 2026-08-11 · deepseek-v4-flash

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗ Review JSON

Pith's one-line read A single SPECT brain slice reveals early Parkinson's disease with 99.08% accuracy.

desk verdict A competent incremental CNN study on PPMI SPECT with a clinically useful SWEDD finding, but the headline accuracy may be inflated by an unclarified hyperparameter search protocol. read the letter →

arxiv 2412.05348 v2 pith:ZJTR6KFP submitted 2024-12-06 eess.IV cs.CVcs.LGstat.AP

R. Prashanth This is my paper · ORCID
classification eess.IVcs.CVcs.LGstat.AP
keywords Parkinson'sdiseaseSPECTimagingconvolutionalneuralnetworkearlydetectionSWEDDBayesianoptimizationcomputer-aideddiagnosis
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

This paper argues that a compact convolutional neural network, trained on a single normalized transaxial slice from SPECT brain scans, can distinguish early Parkinson's disease from healthy controls with near-perfect performance: 99.08% accuracy and 99.93% AUC in ten-fold cross-validation. It also reports that the network recognizes 95% of SWEDD scans—patients clinically diagnosed with PD whose scans show no dopaminergic deficit—as non-PD. The work matters because early PD diagnosis is error-prone and SWEDD patients are frequently treated with medications that do more harm than good. The design deliberately avoids manual feature extraction and region-of-interest placement, relying instead on Bayesian hyperparameter optimization to find a compact two-convolutional-layer architecture. The authors present the model as a diagnostic aid for clinicians rather than a replacement for clinical judgment.

What carries the argument

The load-bearing mechanism is a convolutional neural network whose architecture was selected by Tree-structured Parzen Estimator (TPE), a form of Bayesian hyperparameter optimization. The chosen network has a 5×5 convolution with 64 filters, a 2×2 max pooling, a 3×3 convolution with 32 filters, another max pooling, a flattened dense layer of 16 neurons with 0.2 dropout, and a final two-neuron output. The input is a SPECT slice normalized by dividing intensities by $2^{15}-1$, either the single slice 41 with maximal striatal uptake or the average of slices 35–48, based on prior localization of striatal activity. What carries the argument is the CNN's ability to learn discriminative textural features directly from these slices, which the paper says produces better results than the manual feature engineering used in prior work.

What would settle it

Run the same two-convolutional-layer CNN with the same slice-41 input on a held-out test set (or an external SPECT cohort) that was never used during Bayesian optimization; if accuracy and AUC fall substantially below 99.08% and 99.93%, the central claim of near-perfect early-PD discrimination does not generalize. For the SWEDD result, check follow-up diagnoses: if a sizable fraction of the 76 scans classified as 'normal' are later diagnosed as clinical PD, then framing that classification as 'detection of non-PD' would be incorrect.

Watch

Extended reading notes

Core claim

The paper's central claim is that a Bayesian-optimized CNN with two convolutional layers (64 and 32 filters) and a 16-unit dense layer, applied to slice 41 of a normalized SPECT volume (or the average of slices 35–48), classifies early PD versus normal with accuracy 99.08% and AUC 99.93% on the single-slice input, with the averaged-slice input close behind at 98.32% accuracy and 99.40% AUC. On the separate SWEDD task, the same CNN correctly labels 76 of 80 (95%) SWEDD scans as normal, outperforming logistic regression, linear SVM, and MLP. The authors report that this improves on their earlier shape-analysis approach, which reached 97.29% accuracy and 99.26% AUC, and that the improvement comes from the CNN's learned filters rather than from hand-crafted features. They interpret the few misclassified SWEDD images as showing patterns that deviate from normal, consistent with prior reports that some such cases are later re-diagnosed as PD.

Load-bearing premise

The load-bearing premise is that ten-fold cross-validation with Bayesian hyperparameter optimization performed on the same dataset gives an unbiased estimate of performance; if the model selection leaked test-fold information, the reported 99.08% accuracy and 99.93% AUC are optimistically inflated.

Editorial extensions

If this is right

  • A clinician could submit a single SPECT slice to the model as a second reader, potentially reducing early-stage misdiagnosis in the common situation where clinical symptoms are mild or overlap with essential tremor.
  • If the 95% SWEDD classification rate holds, most SWEDD patients—who currently receive dopaminergic medication despite normal scans—could be spared unnecessary treatment and side effects.
  • Because the model relies on one slice rather than the full-volume 91-slice scan, it is computationally inexpensive and easy to reproduce in standard clinical imaging pipelines.
  • The near-equality of single-slice and averaged-slice results suggests that the diagnostic signal is concentrated in the striatal region and is robust to small variations in slice selection.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

  • A testable implication the paper leaves implicit is that one transaxial slice carries essentially all the diagnostic information for early PD in this imaging protocol; that claim could be checked by comparing against a 3D CNN taking the full volume, which might matter in sites with different SPECT reconstruction or normalization.
  • The misclassified SWEDD cases, which the paper describes as looking 'uneven and dull,' may actually be early PD patients whose diagnosis changes on follow-up; linking the model's errors to the longitudinal labels in the public cohort would make the 'clinical aid' claim stronger and is not reported in the paper.
  • The claimed advantage of Bayesian hyperparameter optimization over manual or grid search in this setting should be verified with nested cross-validation; if verified, the same optimization recipe could transfer to other small-sample medical image classification problems without the optimistic bias risk.
Share X Bluesky LinkedIn Reddit HN

Signed reviews

No signed human review yet.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Referee Report

4 major / 5 minor

Summary. This manuscript develops machine learning classifiers, primarily a compact convolutional neural network (CNN), to distinguish early Parkinson's disease (PD) from healthy normal controls using 123I-Ioflupane SPECT images from the PPMI database, and to flag SWEDD subjects as non-PD. Two image representations are used: the 41st transaxial slice and the average of slices 35–48. Ten-fold cross-validation is applied for evaluation. The CNN with Bayesian hyperparameter optimization reportedly achieves 99.08% accuracy and 99.93% AUC for the single-slice early-PD versus normal task, and identifies 76/80 SWEDD scans as normal. The paper concludes that the models could act as diagnostic aids.

Significance. If the reported performance survives an unbiased evaluation, the contribution is meaningful: a small two-convolution-layer CNN operating on a single SPECT slice, without hand-crafted feature extraction, achieving accuracy comparable or superior to prior work on the same PPMI cohort, with an explicit attempt to address the clinically relevant SWEDD group. The use of Bayesian hyperparameter optimization to obtain a compact architecture is a sensible design goal, and the comparison with logistic regression, SVM, and MLP provides context. However, the reliability of the reported numbers hinges entirely on the evaluation protocol, since the claims are empirical and no external cohort, error bars, or code are provided.

major comments (4)
  1. [II.E and III] The evaluation protocol does not describe how hyperparameters were chosen relative to the cross-validation folds. The text states 'Ten fold cross validation was applied to evaluate the performance' (Sec. II.E) and that for MLP and CNN 'parameters are estimated using Bayesian approximation' (Sec. III), but it does not specify whether the TPE procedure used a separate validation split or was nested within each training fold, nor what objective function was optimized. If the same folds that produced the Table III confusion matrices were used to select architectures, the reported 99.08% accuracy and 99.93% AUC would be optimistically biased. Because the entire clinical-potential claim rests on these numbers, the paper must either describe a nested-CV protocol or re-run the analysis with an independent validation set, and report the TPE search space and number of evaluations.
  2. [III, Table III] The results are single-run point estimates with no uncertainty quantification. For the single-slice CNN, the confusion matrix [439,4;2,208] yields only 6 errors; a single 10-fold CV partition can easily produce a 99% estimate by chance. Without repeated CV with different seeds, bootstrapped confidence intervals, or per-fold metrics, the apparent gap between CNN and the other methods (99.08% vs. 96.0–96.8%) cannot be judged as significant. The SWEDD result '76 out of 80' similarly needs a confidence interval (the exact binomial 95% CI is approximately 87.9–98.7%) to be interpretable.
  3. [III vs. Table II] The CNN architecture is described inconsistently. The text says 'another convolution layer with 32 filters of size 5 x 5,' but Table II lists Conv2D (3 x 3) for the second convolutional layer, and the output shape (50, 41, 32) is compatible only with a 3x3 kernel on the (52, 43, 64) input. This should be corrected, since the compact architecture is a stated contribution.
  4. [III.B] The SWEDD evaluation is a transfer of the PD-vs-normal model to an unseen class, but no decision threshold is given. A CNN output is a 2-unit softmax; it is unclear whether the 'accuracy of 95%' uses 0.5 probability or some other cutoff. Reporting a threshold-independent measure (e.g., AUC on the SWEDD set) and the threshold used would make the result reproducible. Additionally, the clinical interpretation would be strengthened by follow-up diagnosis information, which the authors mention in the discussion of Choi et al. but do not analyze here.
minor comments (5)
  1. [Table I] Table I is misformatted: the HY stage values appear in the Age columns for the early PD and SWEDD groups, making the table hard to read. Please separate the HY stage into its own columns.
  2. [II.E] The phrase 'L1-normalization' to describe L1 regularization in logistic regression and SVM is nonstandard; consider using 'L1 regularization'.
  3. [III] The comparison with prior work ('This work notably improves these metrics' in reference to [27]) would be more convincing if the training and test protocols of the cited studies were aligned; a table listing cohort sizes and evaluation schemes of the cited works would help.
  4. [General] The manuscript would benefit from a statement on data and code availability; no repository or implementation details are provided, which limits reproducibility.
  5. [Figures 3 and 4] The figure captions are not fully self-contained; for example, Fig. 3A and 3B should state in the caption which ground-truth class each misclassified image belongs to, rather than relying on the body text.

Circularity Check

0 steps flagged · score 0.0 of 10

No significant circularity; the paper's headline results are empirical cross-validated evaluations, not quantities forced by construction.

full rationale

The paper's central claim is an empirical performance result: a CNN trained on PPMI SPECT images achieves 99.08% accuracy and 99.93% AUC on a 10-fold cross-validation partition, and the same PD-versus-normal model labels 76 of 80 SWEDD scans as normal. There is no derivation chain in which a predicted quantity is defined in terms of a fitted input. The only self-citation is the slice-selection observation from the author's prior work [27], which identified slices 35-48 and slice 41 as containing the most striatal activity; that observation is used to choose the input images, but it is not a parameter fitted to the test labels and does not by construction determine the CNN's accuracy or AUC. The reported metrics are measured on held-out folds and are not algebraically implied by the preprocessing choice. The concern that Bayesian hyperparameter optimization was not nested inside the cross-validation is a potential validity or optimistic-bias issue, not a circularity issue: the numbers are empirical fits evaluated on data, not quantities that reduce to their own inputs by definition. No equation in the paper defines a target quantity in terms of itself, and no fitted parameter is renamed as a prediction. Therefore no circular step is present.

Assumptions & free parameters 4 free parameters · 4 assumptions · 0 invented entities

The central claim rests on PPMI labels, the slice-selection assumption inherited from prior work, and an evaluation protocol that may leak hyperparameter selection into the test fold.

free parameters (4)
  • Slice range 35-48 and single slice 41 = 35-48, 41
    Chosen based on the author's prior work [27]; a manual selection that affects all input images.
  • CNN architecture hyperparameters = filters 64 and 32, kernels 5x5 and 3x3, dense 16, dropout 0.2
    Selected via Bayesian optimization on PPMI data; no nested cross-validation described.
  • Regularization penalties for logistic regression and SVM = C = 1.0 for LR, C = 0.5 for SVM
    Estimated via cross-validation on the same dataset.
  • MLP hidden units and dropout = 32 neurons, dropout 0.4
    Selected via Bayesian optimization on PPMI data.
assumptions (4)
  • domain assumption PPMI standard SPECT preprocessing (reconstruction, attenuation correction, 3D 6 mm Gaussian filter, MNI normalization) makes scans comparable across sites.
    Invoked in Section II-B; if alignment fails, slice 41 and average slices are not anatomically consistent across subjects.
  • domain assumption Slice 41 and the average of slices 35-48 contain the most relevant striatal information.
    Section II-C relies on prior work [27] without verification on this dataset.
  • domain assumption PPMI clinical labels are reliable ground truth for early PD, normal, and SWEDD.
    Labels define the supervised task; SWEDD labels may change on follow-up, which the paper itself notes.
  • domain assumption Ten-fold cross-validation provides unbiased performance estimates.
    Section II-E; requires that hyperparameter selection does not leak into test folds, which is not explicitly ensured.

how reviews work

0 comments
Cite this review

Pith. "Pith review of Accurate early detection of Parkinson's disease from SPECT imaging through Convolutional Neural Networks." pith.science (2026). https://pith.science/paper/ZJTR6KFP

@misc{pith2026241205348,
  author       = {Pith},
  title        = {Pith review of: Accurate early detection of Parkinson's disease from SPECT imaging through Convolutional Neural Networks},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/ZJTR6KFP}},
  note         = {Machine review of arXiv:2412.05348}
}
read the original abstract

Early and accurate detection of Parkinson's disease (PD) is a crucial diagnostic challenge carrying immense clinical significance, for effective treatment regimens and patient management. For instance, a group of subjects termed SWEDD who are clinically diagnosed as PD, but show normal Single Photon Emission Computed Tomography (SPECT) scans, change their diagnosis as non-PD after few years of follow up, and in the meantime, they are treated with PD medications which do more harm than good. In this work, machine learning models are developed using features from SPECT images to detect early PD and SWEDD subjects from normal. These models were observed to perform with high accuracy. It is inferred from the study that these diagnostic models carry potential to help PD clinicians in the diagnostic process

Discussion (0). Continue with ORCID to comment.

Reference graph

Works this paper leans on

44 extracted references · 43 canonical work pages

  1. [1]

    Parkinson's disease: clinical features and diagnosis,

    J. Jankovic, "Parkinson's disease: clinical features and diagnosis," J Neurol Neurosurg Psychiatry, vol. 79, pp. 368-76, Apr 2008

    work page 2008

  2. [2]

    Description of Parkinson's disease as a clinical syndrome,

    S. Fahn, "Description of Parkinson's disease as a clinical syndrome," Ann N Y Acad Sci, vol. 991, pp. 1-14, Jun 2003

    work page 2003

  3. [3]

    Epidemiology of Parkinson's disease,

    O. B. Tysnes and A. Storstein, "Epidemiology of Parkinson's disease," J Neural Transm (Vienna), vol. 124, pp. 901-905, Aug 2017

    work page 2017

  4. [4]

    The Parkinson Progression Marker Initiative (PPMI),

    K. Marek, D. Jennings, S. Lasch, A. Siderowf, C. Tanner, T. Simuni, et al., "The Parkinson Progression Marker Initiative (PPMI)," Prog Neurobiol, vol. 95, pp. 629-635, 2011

    work page 2011

  5. [5]

    Rapid and ultra -sensitive quantitation of disease - associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT- QuIC,

    B. R. Groveman, C. D. Orrù, A. G. Hughson, L. D. Raymond, G. Zanusso, B. Ghetti, et al., "Rapid and ultra -sensitive quantitation of disease - associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT- QuIC," Acta Neuropathologica Communications, vol. 6, p. 7, 2018/02/09 2018

    work page 2018

  6. [6]

    [123I]FP -CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease,

    J. Booij, G. Tissingh, G. J. Boer, J. D. Speelman, J. C. Stoof, A. G. Janssen, et al., "[123I]FP -CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease," J Neurol Neurosurg Psychiatry, vol. 62, pp. 133-40, Feb 1997

    work page 1997

  7. [7]

    The Role of Functional Dopamine-Transporter SPECT Imaging in Parkinsonian Syndromes, Part 1,

    T. C. Booth, M. Nathan, A. D. Waldman, A. M. Quigley, A. H. Schapira, and J. Buscombe, "The Role of Functional Dopamine-Transporter SPECT Imaging in Parkinsonian Syndromes, Part 1," AJNR Am J Neuroradiol, vol. 36, pp. 236-44, Jun 5 2015

    work page 2015

  8. [8]

    The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration,

    J. L. Cummings, C. Henchcliffe, S. Schaier, T. Simuni, A. Waxman, and P. Kemp, "The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration," Brain, vol. 134, pp. 3146 -66, Nov 2011

    work page 2011

Show all 44 references
  1. [9]

    123 -I Ioflupane SPECT measures of Parkinson disease progression in the Parkinson Progression Marker Initiative (PPMI) trial,

    J. Seibyl, D. Jennings, I. Grachev, C. Coffey, and K. Marek, "123 -I Ioflupane SPECT measures of Parkinson disease progression in the Parkinson Progression Marker Initiative (PPMI) trial," J Nucl Med, vol. 54, pp. 57-58, 2013

    2013

  2. [10]

    Importance of low diagnostic Accuracy for early Parkinson's disease,

    T. G. Beach and C. H. Adler, "Importance of low diagnostic Accuracy for early Parkinson's disease," Movement Disorders, vol. 33, pp. 1551 -1554, 2018

    2018

  3. [11]

    Refining diagnosis of Parkinson's disease with deep learning -based interpretation of dopamine transporter imaging,

    H. Choi, S. Ha, H. J. Im, S. H. Paek, and D. S. Lee, "Refining diagnosis of Parkinson's disease with deep learning -based interpretation of dopamine transporter imaging," Neuroimage Clin, vol. 16, pp. 586-594, 2017

    2017

  4. [12]

    Invalidation of Parkinson's disease diagnosis after years of follow-up based on clinical, radiological and neurophysiological examination,

    G. Coarelli, B. Garcin, E. Roze, M. Vidailhet, and B. Degos, "Invalidation of Parkinson's disease diagnosis after years of follow-up based on clinical, radiological and neurophysiological examination," J Neurol Sci, vol. 406, p. 116454, Sep 9 2019

    2019

  5. [13]

    Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes,

    A. M. Catafau, E. Tolosa, and DaTscan Clinically Uncertain Parkinsonian Syndromes Study Group, "Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes," Movement Di sorders, vol. 19, pp...

    2004

  6. [14]

    A. R. Kupsch, N. Bajaj, F. Weiland, A. Tartaglione, S. Klutmann, M. Buitendyk, et al., "Impact of DaTscan SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use and safety in patients with clinically uncertain parkinsonia...

    2012

  7. [15]

    Long -Term Follow-Up of Patients with Scans without Evidence of Dopaminergic Deficit (SWEDD) in the ELLDOPA Study,

    K. Marek, D. L. Jennings, and J. P. Seibyl, "Long -Term Follow-Up of Patients with Scans without Evidence of Dopaminergic Deficit (SWEDD) in the ELLDOPA Study," Neurology, vol. 64, p. A274, 2005

    2005

  8. [16]

    Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I] -FP-CIT SPECT imaging: the [123I]-FP-CIT study group,

    T. S. Benamer, J. Patterson, D. G. Grosset, J. Booij, K. de Bruin, E. van Royen, et al., "Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I] -FP-CIT SPECT imaging: the [123I]-FP-CIT study group," Movement Disorde rs, vol. 15, pp. 50...

    2000

  9. [17]

    Dopamine Transporter SPECT: How to Remove Subjectivity?,

    C. Scherfler and M. Nocker, "Dopamine Transporter SPECT: How to Remove Subjectivity?," Movement Disorders, vol. 24, pp. S721 –S724, 2009

    2009

  10. [18]

    R. T. Staff, T. S. Ahearn, K. Wilson, C. E. Counsell, K. Taylor, R. Caslake, et al., "Shape analysis of 123I -N-omega-fluoropropyl-2-beta- carbomethoxy-3beta-(4-iodophenyl) nortropane single -photon emission computed tomography images in the assessment of patients with parkins...

    2009

  11. [19]

    Computer -Aided Diagnosis of Parkinson's Disease Using Enhanced Probabilistic Neural Network,

    T. J. Hirschauer, H. Adeli, and J. A. Buford, "Computer -Aided Diagnosis of Parkinson's Disease Using Enhanced Probabilistic Neural Network," J Med Syst, vol. 39, p. 179, Nov 2015

    2015

  12. [20]

    Artificial intelligence in the diagnosis of Parkinson's disease from ioflupane -123 single -photon emission computed tomography dopamine transporter scans using transfer learning,

    D. H. Kim, H. Wit, and M. Thurston, "Artificial intelligence in the diagnosis of Parkinson's disease from ioflupane -123 single -photon emission computed tomography dopamine transporter scans using transfer learning," Nucl Med Commun, vol. 39, pp. 887-893, Oct 2018

    2018

  13. [21]

    Automatic detection of Parkinsonism using significance measures and component analysis in DaTSCAN imaging,

    F. J. Martínez-Murcia, J. M. Górriz, J. Ramírez, I. A. Illán, and A. Ortiz, "Automatic detection of Parkinsonism using significance measures and component analysis in DaTSCAN imaging," Neurocomputing, vol. 126, pp. 58-70, 2014/02/27/ 2014

    2014

  14. [22]

    A 3D Convolutional Neural Network Approach for the Diagnosis of Parkinson’s Disease,

    F. J. Martinez -Murcia, A. Ortiz, J. M. Górriz, J. Ramírez, F. Segovia, D. Salas-Gonzalez, et al., "A 3D Convolutional Neural Network Approach for the Diagnosis of Parkinson’s Disease," in International Work -Conference on the Interplay Between Natural and Artificial Computati...

    2017

  15. [23]

    Computer -aided diagnosis of Parkinson's disease based on [(123)I]FP -CIT SPECT binding potential images, using the voxels -as-features approach and support vector machines,

    F. P. Oliveira and M. Castelo -Branco, "Computer -aided diagnosis of Parkinson's disease based on [(123)I]FP -CIT SPECT binding potential images, using the voxels -as-features approach and support vector machines," J Neural Eng, vol. 12, p. 026008, Apr 2015

    2015

  16. [24]

    Parkinson's Disease Detection Using Isosurfaces -Based Features and Convolutional Neural Networks,

    A. Ortiz, J. Munilla, M. Martínez-Ibañez, J. M. Górriz, J. Ramírez, and D. Salas-Gonzalez, "Parkinson's Disease Detection Using Isosurfaces -Based Features and Convolutional Neural Networks," Front Neuroinform, vol. 13, p. 48, 2019

    2019

  17. [25]

    Automatic classification and prediction models for early Parkinson’s disease diagnosis from SPECT imaging,

    R. Prashanth, S. Dutta Roy, P. K. Mandal, and S. Ghosh, "Automatic classification and prediction models for early Parkinson’s disease diagnosis from SPECT imaging," Expert Systems with Applications, vol. 41, pp. 3333-3342, 2014/06/01/ 2014

    2014

  18. [26]

    High -Accuracy Detection of Early Parkinson's Disease through Multimodal Features and Machine Learning,

    R. Prashanth, S. Dutta Roy, P. K. Mandal, and S. Ghosh, "High -Accuracy Detection of Early Parkinson's Disease through Multimodal Features and Machine Learning," Int J Med Inform, vol. 90, pp. 13-21, Jun 2016

    2016

  19. [27]

    High -Accuracy Classification of Parkinson's Disease Through Shape Analysis and Surface Fitting in 123I -Ioflupane SPECT Imaging,

    R. Prashanth, S. D. Roy, P. K. Mandal, and S. Ghosh, "High -Accuracy Classification of Parkinson's Disease Through Shape Analysis and Surface Fitting in 123I -Ioflupane SPECT Imaging," IEEE Journal of Biomedical and Health Informatics, vol. 21, pp. 794-802, 2017

    2017

  20. [28]

    Improved parkinsonism diagnosis using a partial least squares based approach,

    F. Segovia, J. M. Gorriz, J. Ramirez, I. Alvarez, J. M. Jimenez -Hoyuela, and S. J. Ortega, "Improved parkinsonism diagnosis using a partial least squares based approach," Med Phys, vol. 39, pp. 4395-403, Jul 2012

    2012

  21. [29]

    Automatic assistance to Parkinson's disease diagnosis in DaTSCAN SPECT imaging,

    I. A. Illan, J. M. Gorrz, J. Ramirez, F. Segovia, J. M. Jimenez-Hoyuela, and S. J. Ortega Lozano, "Automatic assistance to Parkinson's disease diagnosis in DaTSCAN SPECT imaging," Med Phys, vol. 39, pp. 5971-80, Oct 2012

    2012

  22. [30]

    Application of Empirical Mode Decomposition (EMD) on DaTSCAN SPECT images to explore Parkinson Disease,

    A. Rojas, J. M. Górriz, J. Ramírez, I. A. Illán, F. J. Martínez -Murcia, A. Ortiz, et al., "Application of Empirical Mode Decomposition (EMD) on DaTSCAN SPECT images to explore Parkinson Disease," Expert Syst. Appl., vol. 40, pp. 2756-2766, 2013

    2013

  23. [31]

    Automatic classification of 123I-FP-CIT (DaTSCAN) SPECT images,

    D. J. Towey, P. G. Bain, and K. S. Nijran, "Automatic classification of 123I-FP-CIT (DaTSCAN) SPECT images," Nucl Med Commun, vol. 32, pp. 699-707, Aug 2011

    2011

  24. [32]

    Machine learning models for the differential diagnosis of vascular parkinsonism and Parkinson’s disease using [123 I] FP-CIT SPECT,

    I. Huertas -Fernandez, F. Garcia -Gomez, D. Garcia -Solis, S. Benitez - Rivero, V. Marin-Oyaga, S. Jesus, et al., "Machine learning models for the differential diagnosis of vascular parkinsonism and Parkinson’s disease using [123 I] FP-CIT SPECT," European journal of nuclear m...

    2015

  25. [33]

    Extraction, selection and comparison of features for an effective automated computer-aided diagnosis of Parkinson’s disease based on [123 I] FP -CIT SPECT images,

    F. P. Oliveira, D. B. Faria, D. C. Costa, M. Castelo -Branco, and J. M. R. Tavares, "Extraction, selection and comparison of features for an effective automated computer-aided diagnosis of Parkinson’s disease based on [123 I] FP -CIT SPECT images," European journal of nuclear ...

    2018

  26. [34]

    Data - Driven Subtyping of Parkinson’s Disease Using Longitudinal Clinical Records: A Cohort Study,

    X. Zhang, J. Chou, J. Liang, C. Xiao, Y. Zhao, H. Sarva, et al., "Data - Driven Subtyping of Parkinson’s Disease Using Longitudinal Clinical Records: A Cohort Study," Scientific Reports, vol. 9, p. 797, 2019/01/28 2019

    2019

  27. [35]

    The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort,

    K. Marek, S. Chowdhury, A. Siderowf, S. Lasch, C. S. Coffey, C. Caspell‐ Garcia, et al., "The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort," Annals of Clinical and Translational Neurology, vol. 5, pp. 1460-1477, 2018

    2018

  28. [36]

    Parkinsonism: onset, progression and mortality,

    M. M. Hoehn and M. D. Yahr, "Parkinsonism: onset, progression and mortality," Neurology, vol. 17, pp. 427-42, May 1967

    1967

  29. [37]

    Deep learning,

    Y. LeCun, Y. Bengio, and G. Hinton, "Deep learning," Nature, vol. 521, pp. 436-444, 2015/05/01 2015

    2015

  30. [38]

    Support -vector networks,

    C. Cortes and V. Vapnik, "Support -vector networks," Machine Learning, vol. 20, pp. 273-297, 1995

    1995

  31. [39]

    Efficient l -1 regularized logistic regression,

    S.-I. Lee, H. Lee, P. Abbeel, and A. Y. Ng, "Efficient l -1 regularized logistic regression," in American Association for Artificial Intelligence (AAAI), 2006, pp. 401-408

    2006

  32. [40]

    Algorithms for hyper- parameter optimization,

    J. S. Bergstra, R. Bardenet, Y. Bengio, and B. Kégl, "Algorithms for hyper- parameter optimization," in Advances in neural information processing systems, 2011, pp. 2546-2554

    2011

  33. [41]

    Dropout: a simple way to prevent neural networks from overfitting,

    N. Srivastava, G. Hinton, A. Krizhevsky, I. Sutskever, and R. Salakhutdinov, "Dropout: a simple way to prevent neural networks from overfitting," The journal of machine learning research, vol. 15, pp. 1929 - 1958, 2014

    1929

  34. [42]

    The effectiveness of data augmentation in image classification using deep learning,

    L. Perez and J. Wang, "The effectiveness of data augmentation in image classification using deep learning," arXiv preprint arXiv:1712.04621, 2017

    2017 arXiv

  35. [43]

    Generative adversarial nets,

    I. Goodfellow, J. Pouget -Abadie, M. Mirza, B. Xu, D. Warde -Farley, S. Ozair, et al., "Generative adversarial nets," in Advances in neural information processing systems, 2014, pp. 2672-2680

    2014

  36. [44]

    When does label smoothing help?,

    R. Muller, S. Kornblith, and G. E. Hinton, "When does label smoothing help?," in Advances in neural information processing systems, 2019, pp. 4696--4705

    2019

Pith tools

Reviewed August 11, 2026 · model on record in the stance chip above.